Pictet Asset Management (Switzerland)’s Nektar Therapeutics NKTR Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio NKTR Stock Details NKTR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$2.62M	Buy
2022 Q4	$2.61M	Buy
2022 Q3	$2.75M	Buy
2022 Q2	$1.31M	Buy
2022 Q1	$74K	Hold
2021 Q4	$186K	Hold
2021 Q3	$247K	Buy